156
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Phenotyping COPD Patients with Emphysema Distribution Using Quantitative CT Measurement; More Severe Airway Involvement in Lower Dominant Emphysema

ORCID Icon, ORCID Icon, , , , ORCID Icon, ORCID Icon, ORCID Icon, & ORCID Icon show all
Pages 2013-2025 | Received 25 Feb 2022, Accepted 21 Jul 2022, Published online: 31 Aug 2022

References

  • Disease GIfCOL. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease 2019 report; 2019.
  • Nakano YMS, Sakai H, Hirai T, et al. Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function. Am J Respir Crit Care Med. 2000;162:1102–1108. doi:10.1164/ajrccm.162.3.9907120
  • Müller NLSC, Miller RR, Abboud RT, Abboud RT. “Density mask”. An objective method to quantitate emphysema using computed tomography. Chest. 1988;94(4):782–787. doi:10.1378/chest.94.4.782
  • Gevenois PADMV, De Vuyst P, Zanen J, Yernault JC. Comparison of computed density and macroscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med. 1995;152(2):653–657. doi:10.1164/ajrccm.152.2.7633722
  • Gevenois PADVP, de Maertelaer V, Zanen J, Jacobovitz D, Cosio MG, Yernault JC. Comparison of computed density and microscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med. 1996;154(1):187–192. doi:10.1164/ajrccm.154.1.8680679
  • Grydeland TB, Dirksen A, Coxson HO, et al. Quantitative computed tomography measures of emphysema and airway wall thickness are related to respiratory symptoms. Am J Respir Crit Care Med. 2010;181(4):353–359. doi:10.1164/rccm.200907-1008OC
  • Lynch DA, Austin JH, Hogg JC, et al. CT-definable subtypes of chronic obstructive pulmonary disease: a statement of the Fleischner society. Radiology. 2015;277(1):192–205. doi:10.1148/radiol.2015141579
  • Thurlbeck WMMN, Müller NL. Emphysema: definition, imaging, and quantification. Am J Roentgenol. 1994;163(5):1017–1025. doi:10.2214/ajr.163.5.7976869
  • Kim WDED, Izquierdo JL, Ghezzo H, Saetta MP, Cosio MG, Cosio MG. Centrilobular and panlobular emphysema in smokers: two distinct morphologic and functional entities. Am Rev Respir Dis. 1991;144(6):1385–1390. doi:10.1164/ajrccm/144.6.1385
  • Kim WDLS, Coxson HO, English JC, et al. The association between small airway obstruction and emphysema phenotypes in COPD. Chest. 2007;131(5):1372–1378. doi:10.1378/chest.06-2194
  • Takahashi M, Fukuoka J, Nitta N, et al. Imaging of pulmonary emphysema: a pictorial review. Int J Chron Obstruct Pulmon Dis. 2008;3(2):193. doi:10.2147/COPD.S2639
  • Eriksson S. Studies in alpha 1-antitrypsin deficiency. Acta Med Scand Suppl. 1965;432:1–85.
  • Kim SS, Seo JB, Lee HY, et al. Chronic obstructive pulmonary disease: lobe-based visual assessment of volumetric CT by Using standard images–comparison with quantitative CT and pulmonary function test in the COPDGene study. Radiology. 2013;266(2):626635. doi:10.1148/radiol.12120385
  • Dirksen AWM, Wille MMW. Computed tomography–based subclassification of chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2016;13(Supplement 2):S114–117. doi:10.1513/AnnalsATS.201503-178KV
  • Mitchell RS, Silvers GW, Goodman N, Dart G, Maisel JC. Are centrilobular emphysema and panlobular emphysema two different diseases? Hum Pathol. 1970;1(3):433441. doi:10.1016/S0046-8177(70)80076-4
  • Group COCW, Barr RG, Berkowitz EA, et al. A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation. COPD. 2012;9(2):151–159. doi:10.3109/15412555.2012.654923
  • Vestbo JEL, Scanlon PD, Yates JC, et al.; ECLIPSE Investigators. Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med. 2011;365(13):1184–1192. doi:10.1056/NEJMoa1105482
  • Yoo JWHY, Seo JB, Chae EJ, et al. Comparison of clinico-physiologic and CT imaging risk factors for COPD exacerbation. J Korean Med Sci. 2011;26(12):1606–1612. doi:10.3346/jkms.2011.26.12.1606
  • Oh YMSS, Park JH, Jin UR, et al. Emphysematous phenotype is an independent predictor for frequent exacerbation of COPD. Int J Tuberc Lung Dis. 2014;18(12):1407–1414. doi:10.5588/ijtld.14.0205
  • Han MKKE, Lynch DA, Liu LX, et al. COPDGene Investigators. Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes. Radiology. 2011;261(1):274–282. doi:10.1148/radiol.11110173
  • Haruna AMS, Nakano Y, Ohara T, et al. CT scan findings of emphysema predict mortality in COPD. Chest. 2010;138(3):635–640. doi:10.1378/chest.09-2836
  • Martinez FJFG, Curtis JL, Criner G, et al.; NETT Research Group. Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Respir Crit Care Med. 2006;173(12):1326–1334. doi:10.1164/rccm.200510-1677OC
  • Madani AZJ, de Maertelaer V, Gevenois PA, Gevenois PA. Pulmonary emphysema: objective quantification at multi-detector row CT–comparison with macroscopic and microscopic morphometry. Radiology. 2006;238(3):1036–1043. doi:10.1148/radiol.2382042196
  • Bastos HNNI, Redondo M, Cunha R, Pereira JM, Magalhães A, Fernandes G. Influence of emphysema distribution on pulmonary function parameters in COPD patients. J Bras Pneumol. 2015;41(6):489–495. doi:10.1590/s1806-37562015000000136
  • Nakano YSH, Muro S, Hirai T, Oku Y, Nishimura K, Mishima M. Comparison of low attenuation areas on computed tomographic scans between inner and outer segments of the lung in patients with chronic obstructive pulmonary disease: incidence and contribution to lung function. Thorax. 1999;54(5):384–389. doi:10.1136/thx.54.5.384
  • Mair GMJ, McAllister D, Maclay J, Connell M, Murchison JT, MacNee W. Computed tomographic emphysema distribution: relationship to clinical features in a cohort of smokers. Eur Respir J. 2009;33(3):536–542. doi:10.1183/09031936.00111808
  • Chae EJSJ, Song JW, Kim N, et al. Slope of emphysema index: an objective descriptor of regional heterogeneity of emphysema and an independent determinant of pulmonary function. Am J Roentgenol. 2010;194(3):W248–255. doi:10.2214/AJR.09.2672
  • Hughes JAHD, Bellamy D, Dowd DE, Ryan KC, Hugh-Jones P. Annual decline of lung function in pulmonary emphysema: influence of radiological distribution. Thorax. 1982;37(1):32–37. doi:10.1136/thx.37.1.32
  • Tanabe NMS, Tanaka S, Sato S, et al. Emphysema distribution and annual changes in pulmonary function in male patients with chronic obstructive pulmonary disease. Respir Res. 2012;13:31. doi:10.1186/1465-9921-13-31
  • Park J, Hobbs BD, Crapo JD, et al. Subtyping COPD by using visual and quantitativeCT imaging features. Chest. 2020;157(1):47–60. doi:10.1016/j.chest.2019.06.015
  • Firdaus AA, Mohamed Hoesein MS, Onno M, et al. Discriminating dominant computed tomography phenotypes in smokers without or with mild COPD. Respir Med. 2014;108:136–143. doi:10.1016/j.rmed.2013.08.014
  • Mohamed Hoesein FA, de Jong PA, Lammers JW, et al. Contribution of CT quantified emphysema, air trapping and airway wall thickness on pulmonary function in male smokers with and without COPD. COPD. 2014;11(5):503–509. doi:10.3109/15412555.2014.933952
  • Nambu AZJ, Schroeder J, Jin G, et al. Quantitative computed tomography measurements to evaluate airway disease in chronic obstructive pulmonary disease: relationship to physiological measurements, clinical index and visual assessment of airway disease. Eur J Radiol. 2016;85(11):2144–2151. doi:10.1016/j.ejrad.2016.09.010
  • Boueiz ACY, Cho MH, Washko GR, et al.; COPDGene Investigators. Lobar emphysema distribution is associated with 5-year radiological disease progression. Chest. 2018;153(1):65–76. doi:10.1016/j.chest.2017.09.022
  • Park TSLJ, Seo JB, Hong Y, et al.; KOLD Study Group. Study design and outcomes of Korean Obstructive Lung Disease (KOLD) cohort study. Tuberc Respir Dis. 2014;76(4):169–174. doi:10.4046/trd.2014.76.4.169
  • Hurst JRVJ, Anzueto A, Locantore N, et al.; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128–1138. doi:10.1056/NEJMoa0909883
  • Crapo RO, Hankinson JL, Irvin C, et al. Standardization of spirometry, 1994 update. American Thoracic Society. Am J Respir Crit Care Med. 1995;152(3):1107–1136.
  • Kim CSJ, Lee SM, Lee JS, et al. Exertional desaturation as a predictor of rapid lung function decline in COPD. Respiration. 2013;86(2):109–116. doi:10.1159/000342891
  • Charlson MEPP, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–383. doi:10.1016/0021-9681(87)90171-8
  • Wood SAZE, Hoford JD, Hoffman EA, Mitzner W, Mitzner W. Measurement of three-dimensional lung tree structures by using computed tomography. J Appl Physiol. 1995;79(5):1687–1697. doi:10.1152/jappl.1995.79.5.1687
  • Lee YKOY, Lee JH, Kim EK, et al.; KOLD Study Group. Quantitative assessment of emphysema, air trapping, and airway thickening on computed tomography. Lung. 2008;186(3):157–165. doi:10.1007/s00408-008-9071-0
  • Kim WJ, Oh YM, Sung J, et al. Lung function response to 12-week treatment with combined inhalation of long-acting beta2 agonist and glucocorticoid according to ADRB2 polymorphism in patients with chronic obstructive pulmonary disease. Lung. 2008;186(6):381–386. doi:10.1007/s00408-008-9103-9
  • Lee JHLY, Kim EK, Kim TH, et al. Responses to inhaled long-acting beta-agonist and corticosteroid according to COPD subtype. Respir Med. 2010;104(4):542–549. doi:10.1016/j.rmed.2009.10.024
  • Kim V, Crapo J, Zhao H, et al. Comparison between an alternative and the classic definition of chronic bronchitis in COPDGene. Ann Am Thorac Soc. 2015;12(3):332–339. doi:10.1513/AnnalsATS.201411-518OC
  • Martínez-García MÁS-CJ, Donat Sanz Y, Catalán Serra P, Agramunt Lerma M, Ballestín Vicente J, Perpiñá-Tordera M. Factors associated with bronchiectasis in patients with COPD. Chest. 2011;140(5):1130–1137. doi:10.1378/chest.10-1758
  • Martinez-Garcia MA, Dl RCD, Soler-Cataluna JJ, et al. Prognostic value of bronchiectasis in patients with moderate-to-severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187(8):823–831. doi:10.1164/rccm.201208-1518OC
  • Saitoh TKH, Shijubo N, Tanaka H, Sugaya F. Lobar distribution of emphysema in computed tomographic densitometric analysis. Invest Radiol. 2000;35(4):235–243. doi:10.1097/00004424-200004000-00004
  • Lim JUKE, Lim SY, Lim SY, et al. Mixed phenotype of emphysema and airway wall thickening is associated with frequent exacerbation in COPD patients. Int J Chronic Obstructive Pulmon Dis. 2019;14:3035–3042. doi:10.2147/COPD.S227377
  • Youlim Kim SHK, Chin Kook R, Jae Seung L, et al. Park air trapping and the risk of COPD exacerbation: analysis from prospective KOCOSS cohort. Front Med. 2022. doi:10.3389/fmed.2022.835069
  • McCartney CT, Weis MN, Ruppel GL, Nayak RP. Residual Volume and total lung capacity to assess reversibility in obstructive lung disease. Respir Care. 2016;61(11):1505–1512. doi:10.4187/respcare.04323
  • Hesselbacher SERR, Schabath MB, Smith EO, et al. Cross-sectional analysis of the utility of pulmonary function tests in predicting emphysema in ever smokers. Int J Environ Res Public Health. 2011;8(5):1324–1340. doi:10.3390/ijerph8051324
  • Washko GRHE, Reilly JJ, Reilly JJ. Radiographic evaluation of the potential lung volume reduction surgery candidate. Proc Am Thorac Soc. 2008;5(4):421–426. doi:10.1513/pats.200802-017ET
  • Stavngaard TSS, Bach KS, Stoel BC, Dirksen A, Dirksen A. Quantitative assessment of regional emphysema distribution in patients with chronic obstructive pulmonary disease (COPD). Acta Radiol. 2006;47(9):914–921. doi:10.1080/02841850600917170
  • Dirksen A, MacNee W. The search for distinct and clinically useful phenotypes in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;188(9):1045–1051. doi:10.1164/rccm.201309-1649ED